Good news for Canberrans affected by hepatitis C
Media Release For Immediate Release 24 April 2015 Hepatitis ACT today welcomed Pharmaceutical Benefits Advisory Committee (PBAC) recommendations to Government to subsidise new antiviral medicines for the treatment of chronic hepatitis C. Executive Officer of Hepatitis ACT, John Didlick said “Access to these new drugs under the Pharmaceutical Benefits Scheme (PBS) is incredibly important and […]